bucladesine has been researched along with Rectal Neoplasms in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (66.67) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ahmed, OA; Mangeat, P; Marchis-Mouren, G; Marvaldi, J | 1 |
Castigli, E; Leli, U; Mercati, U; Mezzasoma, I | 1 |
Cho-Chung, YS; Clair, T; Greiner, JW; Guadagni, F; Roselli, M; Schlom, J; Tortora, G | 1 |
3 other study(ies) available for bucladesine and Rectal Neoplasms
Article | Year |
---|---|
Parallel activation of cyclic AMP phosphodiesterase and cyclic AMP-dependent protein kinase in two human gut adenocarcinoma cells (HT 29 and HRT 18) in culture, by vasoactive intestinal peptide (VIP) and other effectors activating the cyclic AMP system.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Adenocarcinoma; Animals; Bucladesine; Catecholamines; Cells, Cultured; Colonic Neoplasms; Cyclic AMP; Enzyme Activation; Gastrointestinal Hormones; Prostaglandins E; Protein Kinases; Rectal Neoplasms; Secretin; Vasoactive Intestinal Peptide | 1981 |
[Changes in phosphatidylserine synthesis in human rectal tumors].
Topics: Adenocarcinoma; Bucladesine; Humans; Intestinal Mucosa; Phosphatidylserines; Rectal Neoplasms | 1979 |
Carcinoembryonic antigen regulation in human colorectal tumor cells by a site-selective cyclic AMP analogue: a comparison with interferon-gamma.
Topics: 8-Bromo Cyclic Adenosine Monophosphate; Animals; Antibodies, Monoclonal; Antineoplastic Agents; Bucladesine; Carcinoembryonic Antigen; Cell Line; Colonic Neoplasms; Colorectal Neoplasms; Dose-Response Relationship, Drug; Histocompatibility Antigens Class I; Humans; Interferon-gamma; Kinetics; Mice; Mice, Nude; Radioimmunoassay; Recombinant Proteins; Rectal Neoplasms; Transplantation, Heterologous | 1991 |